|
Enzon Pharmaceuticals, Inc. - Company Profile Snapshot
| Company Profile: |
Enzon Pharmaceuticals, Inc. |
| Ticker: |
ENZN |
| Exchanges: |
NAS |
| 2008 Sales: |
196,940,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
351 |
Business Description
Enzon Pharmaceuticals, Inc.. The Group's principal activity is to develop, manufacture and sell human therapeutics for life-threatening diseases. The Group includes three segments: Product sale which manufactures markets and sells pharmaceutical products for patients with cancer and other life-threatening diseases. Royalties, a source of revenue which is derived from sales of marketed products from PEG-INTRON, PEGASYS and MACUGEN that utilize our proprietary technology. Contract Manufacturing, where we utilize a portion of our excess manufacturing capacity to provide contract manufacturing services for a number of injectable products, such as single- and dual-chamber vial filling and lipid Complex formulations. The Group's products include ABELCET, ADAGEN, DEPOCYT and ONCASPAR.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
